Endoscopic ultrasound highly accurate in evaluating ambiguous radiographic findings of the pancreas

August 28, 2008

Researchers from St. Louis University School of Medicine in Missouri report that EUS and EUS-FNA is 99.1 percent accurate in diagnosing pancreatic neoplasms (abnormal growths or tumors) in patients who were referred for endoscopic ultrasound (EUS) because of CT and/or MRI reports of two common, though somewhat ambiguous findings - enlargement of head of pancreas (HOP) or dilation of the pancreatic duct (PD). The study appears in the August issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).

Occasionally, patients who are asymptomatic or who have nonspecific symptoms, such as weight loss and abdominal pain, have subtle abnormal or incidental findings on CT and/or MRI that raise suspicion for pancreatic cancer. These tests have relatively low specificity (ability to definitively discern between various diagnoses) in this setting. Perhaps due to a concern of missing early, small pancreatic cancers, physicians who perform EUS are increasingly referred patients with subtle CT or MRI findings such as ''enlarged pancreatic head" or ''dilation of the pancreatic duct (widening of the main duct coursing through the pancreas)." Endoscopic ultrasound and endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) have become a valuable tool in the diagnostic evaluation of patients with suspected pancreatic cancer. This technique allows for detection and possible needle biopsy of small pancreatic tumors even before they can be visualized as a discrete mass with CT or MRI. According to the American Cancer Society, deaths from pancreatic cancer in 2008 are estimated to be approximately 34,000.

"Often, patients with these radiologic findings are referred for EUS in lieu of waiting for repeated imaging. Our study looked to determine the performance characteristics of EUS and/or EUS with FNA in diagnosing a pancreatic tumor in this patient population," said study lead author Banke Agarwal, MD, Saint Louis University School of Medicine. "We found that EUS and/or an EUS-FNA for diagnosing a pancreatic neoplasm was 99.1 percent accurate with 88.8 percent sensitivity and 100 percent specificity."

Endoscopic ultrasound consists of a flexible endoscope which has a small ultrasound device built into the end. The ultrasound component produces sound waves that create visual images of the digestive tract which extend beyond the inner surface lining. EUS can be used to evaluate an abnormality below the surface such as a growth that was detected at a prior endoscopy or by X-ray. EUS can also be used to diagnose diseases of the pancreas, bile duct, and gallbladder when other tests are inconclusive, and can be used to determine the stage of cancers. Tissue samples, using a fine needle aspiration technique (FNA), can be obtained in real time with EUS guidance should an abnormality be seen.

Patients and Methods

This study was a retrospective analysis of 110 patients, mean age 60.3 years, from a prospectively maintained database of patients who underwent an EUS and/or EUS-FNA at St. Louis University Hospital between March 2002 and March 2006 for suspected pancreatic cancer based on an abnormal CT and/or MRI who were reported as having an enlarged HOP or dilation of the PD (with or without a dilated common bile duct). An EUS examination was initially performed by using a radial echoendoscope. Whenever a suspicious "mass" was identified on radial EUS, an FNA was performed using a linear echoendoscope. Fine needle aspirates were submitted for cytology and biochemical analysis. A final diagnosis was based on definitive cytology, surgical pathology or clinical follow up of 12 months or more (median follow up was 16 months).

Results

Researchers found that 6 percent of patients referred because of an enlarged HOP on a CT and/or an MRI and 11.5 percent of patients referred for a dilated PD had a pancreatic neoplasm. The diagnostic accuracy of an EUS and/or EUS-FNA in these patients for diagnosing a pancreatic neoplasm was 99.1 percent. Furthermore, no patient with enlarged HOP, but without a mass at EUS, went on to develop cancer.

In conclusion, researchers found that a pancreatic neoplasm is present in a clinically significant number of patients with an ''enlarged HOP'' or "dilated PD" detected on a CT and/or MRI performed for evaluation of nonspecific symptoms, such as abdominal pain or weight loss. They also observed that an EUS and/or EUS-FNA are highly accurate for the diagnosis of pancreatic neoplasm in these patients. Based on these data, researchers recommend that an EUS and/or EUS-FNA be considered as the logical next test in the evaluation of patients with such imaging findings.

American Society for Gastrointestinal Endoscopy

---

---

	Pancreatic Cancer: A Patient and His Doctor Balance Hope and Truth (A Johns Hopkins Press Health Book) by Michael J. Lippe (Author), Dung T. Le (Author) Michael J. Lippe was diagnosed with pancreatic cancer in 2007. This is his story, and the story of pancreatic cancer, narrated by Lippe and Dr. Dung T. Le, the physician who is treating him.In telling these stories, Lippe and Le alternate chapters. Lippe writes about the early signs that something was wrong; Le continues with a description of pancreatic cancer, its symptoms, and its treatments. Lippe talks about his prognosis, contemplates the prospect of death, and describes how he began to cope; Le explains the importance, for both doctor and patient, of balancing hope and truth. Lippe speaks frankly about the toll the disease takes on his marriage and family; Le offers a general picture of what most patients can expect with their illness. The book concludes with Lippe and Le’s...
	The Pancreatic Oath by Candice P. Rosen (Author) A revolutionary guide to Self-Health! Are you one of millions who fuel the billion dollar diet industry? Diet after diet...you've tried and yet have failed to achieve your long-term goals. You are not alone. The Pancreatic Oath is a revolutionary new book from registered nurse, licensed social worker and certified health counselor Candice Rosen that introduces the cutting-edge Pancreatic Nutritional Program (PNP). Simply, the PNP provides readers with an understanding of how their body processes the food they choose to eat, how it affects their pancreas, and the domino effect that poor choices have on their weight and their health. In this groundbreaking new book you will learn about: Pancreatic abuse-signs and causes The relationship between the pancreas, diabetes and...
	Pancreatic Cancer: It's a Family Affair by Lisa M Strahs-Lorenc (Author) This is not another book about cancer. The 22 contributors from 20 families who have contributed their stories, their feelings and their advice have done so in order to help others feel that they are not alone. They represent spouses, siblings, adult children and patients themselves. There are 4 survivors as of the writing of this book. In addition, all proceeds from the sale of this book will be going to the Lustgarten Foundation and the Pancreatic Cancer Action Network that offer support and research for an eventual cure of this deadly disease.
	Johns Hopkins Patients' Guide to Pancreatic Cancer (Johns Hopkins Medicine) by Nita Ahuja (Author), JoAnn Coleman (Author) The Johns Hopkins Patients Guide to Pancreatic Cancer is a concise, easy-to-follow how to guide that puts you on a path to wellness by explaining pancreatic cancer treatments from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and provides valuable tools to help you to put together your plan of care. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.
	100 Questions & Answers About Pancreatic Cancer, Second Edition by Eileen O'Reilly (Author), Joanne Frankel Kelvin (Author) Whether you re a newly diagnosed pancreatic cancer patient, a survivor, or a friend or relative of someone with pancreatic cancer, this book offers help. The only text to provide a doctor s and patient s view, 100 Questions & Answers About Pancreatic Cancer, Second Edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. The authors, a medical oncologist and a nurse with 25 years of experience with cancer patients, provide a comprehensive, step-by-step discussion of what you can expect in the diagnosis and treatment of pancreatic cancer, while patient commentaries provide a real-life understanding of what these steps might mean for your day-to-day life. This book is an invaluable...
	Surviving: How We Loved Through Pancreatic Cancer by K. Blake Cash (Author) "Emma was still channeling Rocky Balboa, talking about how she was going to beat cancer. She defined survival as completely defeating the disease. I defined survival as weathering the storm with grace. She was so strong, surviving on the force of her will. But her body wasn't cooperating, no matter how hard her spirit fought" "Surviving" is the story of one couple's journey with cancer, from diagnosis to death, written by the surviving member of that couple, K. Blake Cash "Beautifully told . . . honest as an arrow" -author and humorist Barry Parham "a beautiful piece of work . . . I know in my heart that she is "out and about" watching over us even now" -Dr. Harish Lavu, Assistant Professor of Surgery, Thomas Jefferson University
	The Ride Of My Life: A Fight To Survive Pancreatic Cancer by Bob Brown (Author) Insightful, humorous, and inspiring memoir of self-described "regular guy" Bob Brown's courageous battle with pancreatic cancer and his journey through the medical community to save his life. In a conversational tone that feels like you're chatting with a lifelong friend, Bob shares the play-by-play of his fight to stay alive and make the right treatment decisions, affirms the difference a positive attitude can make, and celebrates the unexpected gift of a new perspective on life. What would you do upon hearing your doctor utter the words "inoperable pancreatic cancer"? If you or someone you love has been diagnosed, this amazing story of survival will move you, amuse you, and instill hope in your heart.
	Atlas of Pancreatic Cytopathology: With Histopathologic Correlations by Syed Ali MD (Author), Yener Erozan MD (Author), Ralph Hruban MD (Author) Clinical and radiologic examinations cannot reliably distinguish benign or inflammatory pancreatic disease from carcinoma. The increased use of pancreatic fine needle aspiration (FNA) along with advances in imaging techniques and the introduction of endoscopic ultrasound guidance have led to significantly better detection and recognition of pancreatic masses. Consequently, pancreatic cytopathology is integral to accurate pre-operative diagnosis yet it is a challenging diagnostic area with a variety of potential pitfalls and "look-alike" lesions. Skillful recognition and an awareness of the limitations of the procedure are essential in avoiding misdiagnosis of these dangerous lesions. Atlas of Pancreatic Cytopathology with Histopathologic Correlations fills a void in current pathology...
	Surprised by God: With Pancreatic Cancer by Susan D. Smith (Author)
	WHAT COULD BE CAUSING CHRONIC ABDOMINAL PAIN?: Anything from common peptic ulcers to uncommon pancreatic trauma (Postgraduate Medicine) by JTE Multimedia Establishing a reasonable diagnosis and treatment plan in patients with chronic abdominal pain can be difficult and frustrating. Most cases involve a common and readily identified condition (eg, gallbladder disease, GERD, irritable bowel syndrome). Other cases, however, resist ready diagnosis because they offer no intra-abdominal explanation. In this article, the authors summarize several diverse possibilities as the source of the pain, and they describe how to approach evaluation to avoid unnecessary testing. Original Publication Date: September 1999